Drug Shortage Report for LEVITRA
Report ID | 49555 |
Drug Identification Number | 02250462 |
Brand name | LEVITRA |
Common or Proper name | Vardenafil tablets |
Company Name | BAYER INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | VARDENAFIL |
Strength(s) | 5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 4's |
ATC code | G04BE |
ATC description | OTHER UROLOGICALS, INCL ANTISPASMODICS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2018-06-30 |
Actual start date | |
Estimated end date | Unknown |
Actual end date | 2020-11-16 |
Shortage status | Resolved |
Updated date | 2023-07-14 |
Company comments | DIN discontinued as of November 16, 2020. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2920 MATHESON BLVD EAST MISSISSAUGA, ONTARIO CANADA L4W 5R6 |
Company contact information | 1-800-265-7382 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v3 | 2018-05-16 | French | Compare |
v2 | 2018-05-16 | English | Compare |
v1 | 2018-05-16 | English | Compare |